Anlon Healthcare

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
149.00
-4.4 (-2.87%)
BSENSE

Dec 05

BSE+NSE Vol: 46.6 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024

Compare Profit and Loss Results of Anlon Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
120.00
661.00
-541.00
-81.85%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
120.00
661.00
-541.00
-81.85%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-2.00
5.00
250.00%
Raw Materials Consumed
71.00
501.00
-430.00
-85.83%
Power & Fuel Cost
2.00
12.00
-10.00
-83.33%
Employee Cost
4.00
23.00
-19.00
-82.61%
Operating Expenses
2.00
28.00
-26.00
-92.86%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
10.00
-9.00
-90.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
19.00
-18.00
-94.74%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
599.00
-511.00
-85.31%
Operating Profit (PBDIT) excl Other Income
32.00
61.00
-29.00
-47.54%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
32.00
70.00
-38.00
-54.29%
Interest
3.00
1.00
2.00
200.00%
Profit before Depriciation and Tax
28.00
69.00
-41.00
-59.42%
Depreciation
1.00
8.00
-7.00
-87.50%
Profit Before Taxation & Exceptional Items
26.00
61.00
-35.00
-57.38%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26.00
61.00
-35.00
-57.38%
Provision for Tax
6.00
13.00
-7.00
-53.85%
Profit After Tax
20.00
47.00
-27.00
-57.45%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
156.00
-154.00
-98.72%
Profit Available for appropriations
22.00
203.00
-181.00
-89.16%
Appropriations
22.00
203.00
-181.00
-89.16%
Equity Dividend (%)
0%
30%
-30.00
Earnings Per Share
6.37
9.45
-3.08
-32.59%
Profit And Loss - Net Sales
Net Sales 120.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

Profit And Loss - Interest
Interest 3.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 20.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024